Physician profile
Danielle Ivey
NPI 1629505748
$2,087.40
in general payments reported to CMS, 2019-2025
34 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $101 · 2021: $694 · 2022: $637 · 2023: $489 · 2024: $33.67 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $654.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $335.96 | 2020-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $183.50 | 2020-2023 | Jardiance, Mounjaro |
| Abbvie INC. | $163.41 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.64 | 2021-2023 | Xifaxan, Trulance |
| Sanofi-Aventis U.S. LLC | $108.29 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $101.06 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.31 | 2021-2022 | |
| Glaxosmithkline, LLC. | $93.24 | 2022-2023 | Shingrix, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $92.03 | 2020-2023 | Trintellix |
| Abbott Laboratories | $89.39 | 2021-2025 | Freestyle Libre |
| Eisai INC. | $62.69 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $51.64 | 2021-2023 | Fasenra, Breztri |
| Amgen INC. | $51.22 | 2021 | |
| Dexcom, INC. | $49.30 | 2021-2024 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $47.46 | 2025 | Inspire |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $42.32 | 2025 | |
| Novartis Pharmaceuticals Corporation | $37.26 | 2022 | |
| Jazz Pharmaceuticals INC. | $36.28 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.62 | 2021-2022 | |
| Amarin Pharma, INC. | $30.51 | 2021-2022 | |
| Stryker Corporation | $28.09 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Daiichi Sankyo INC. | $27.50 | 2023 | Injectafer |
| Genentech USA, INC. | $21.50 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $21.04 | 2022 | |
| Lundbeck LLC | $20.99 | 2022 | |
| Bausch Health US, LLC | $19.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.17 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $17.19 | 2022 | |
| Seqirus USA INC | $16.75 | 2022 | |
| Exact Sciences Corporation | $15.37 | 2023 | Cologuard Collection Kit |
| Antares Pharma, INC. | $12.53 | 2021 | |
| Si-Bone, INC. | $12.24 | 2021 | |
| Ibsa Pharma INC. | $11.95 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Ivey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.